An official website of the United States government
Home
Name
HiC-COM
Alternate names
None
Primary Site
None
Histology
None
Radiation
None
Remarks
None
Drugs for HiC-COM
Name
Alternate Names
None
Abbreviations
None
Category
Ancillary Agent
Subcategory
Artificial cerebrospinal fluid
NSC Number
614386
Primary Site
None
Histology
None
Remarks
FDA approved diluent for intrathecal therapy for leukemia and lymphoma. Active Ingredient: Sodium chloride 730 mg; sodium bicarbonate 190 mg; glucose monohydrate 80 mg; magnesium sulfate heptahydrate 30 mg; potassium chloride 30 mg; calcium chloride dihydrate 20 mg; dibasic sodium phosphate heptahydrate 20 mg; phenolsulphonphthalein 10 micrograms; water to 100 mL
Coding
This drug should NOT be coded
Name
Alternate Names
1 Zyloprim
Alloprin
Allopur
Apo-Allopurinol
Atisuril
Bloxanth
BW-56-158
Epidropal
Foligan
Gotax
HPP
Lopurin
Milurit
Novo-Purol
Purinol
Riva-Purinol
Uricemil
Uriprim
Urosin
Zurinol
Zyloprim
Zyloric
Abbreviations
ALLO
HPP
Category
Ancillary Agent
Subcategory
None
NSC Number
001390
1390
Primary Site
None
Histology
None
Remarks
A xanthine oxidase inhibitor indicated in the treatment of hyperuricemia, which is often observed in leukemia, lymphoma, polycythemia vera, myeloid metaplasia, and malignancies in patients receiving cancer chemo.
Coding
This drug should NOT be coded
Name
Alternate Names
Calcium folinate
Calcium leucovorin
Calcium leucovorin rescue
Citrovorum Factor
Citrovorum factor rescue
Folic acid
Folinic Acid
Lederfoline
Leucosar
Leucovorin Calcium
Leucovorin rescue
Wellcovorin
Abbreviations
C.F.
CF
CL
Category
Ancillary Agent
Subcategory
None
NSC Number
3590
003590
Primary Site
None
Histology
None
Remarks
The pharmacologically active form of folic acid. FDA approved uses as 1st line colorectal carcinoma in combination with 5-FU and to diminish methotrexate toxicity.
Coding
This drug should NOT be coded
Name
Alternate Names
Amethopterin
Antifolan
CL-14377
Folex
Methotrexate Sodium
Mexate
Mexate AQ
Rheumatrex
WR-19039
Abbreviations
MTX
Category
Chemotherapy
Subcategory
Antimetabolite
NSC Number
740
000740
Primary Site
Bladder cancer
Breast
Gestational trophoblastic cancer
lymphoma
Meningeal leukemia
Non-Hodgkin lymphoma
Osteogenic sarcoma
Histology
None
Remarks
FDA approved uses on ALL, breast cancer, choriocarcinoma, head and neck cancer, lymphoma, and osteosarcoma.
Coding
This drug should be coded
Name
Alternate Names
AC-1075
Alexan
Ara-cytidine
Arabinocytidine
Arabinosylcytosine
Beta-Arabinosylcytosine
Cytarabin
Cytarabine
Cytarabinoside
Cytosar
Cytosar-U
Cytosine Arabinoside
Cytosine arabinoside hydrochloride
Spongocytidine HCL
Tarabine
Tarabine PFS
U-19920
U-19920A
WR-28453
Abbreviations
ara-C
CA
HDA
HDARA-C
Category
Chemotherapy
Subcategory
Antimetabolite
NSC Number
063878
63878
Primary Site
Histology
None
Remarks
Antineoplastic agent; antimetabolite. FDA approved uses on Hodgkin's disease, leukemia; under investigation for Rx of Progressive Multifocal Leukoencephalopathy (PML)
Coding
This drug should be coded
Name
Alternate Names
Asta B 518
B-518
Clafen Claphene
Cyclophosphamid
Cyclophosphan
Cyclophosphane
Cytophosphan
Cytoxan
Endoxan
Endoxana
Enduxan
Genoxal
Neosar
Procytox
Sendoxan
Tymtram
WR-138719
Abbreviations
CP
CPM
CTX
CTY
CYC
Cyclo
CYT
CYTOX
CYTX
Category
Chemotherapy
Subcategory
Alkylating agent
NSC Number
026271
26271
Primary Site
Histology
None
Remarks
An effective antineoplastic agent and is used for a variety of cancers. FDA approved uses on breast cancer, ovarian carcinoma, leukemia, lymphomas, multiple myeloma, neuroblastma, retinoblastoma, soft tissue sarcoma, Wilm's tumor. Alkylating agent
Coding
This drug should be coded
Name
Alternate Names
Compound 37231
Leurocristine Sulfate
Oncovin
Vincasar
Vincasar PFS
Vincristine Sulfate
Vincrystine
Vinkristin
Abbreviations
LCR
VCR
VNCR
Category
Chemotherapy
Subcategory
Plant alkyloid--antimetabolite
NSC Number
067574
67574
Primary Site
None
Histology
None
Remarks
Antineoplastic; vinca plant alkaloid; antimetabolite. FDA approved uses in ALL, Hodgkin's lymphoma, non-Hodgkin's lymphoma, neuroblastoma, rhabomyosarcoma, and Wilm's tumor.
Coding
This drug should be coded
